The deal, announced late last month, will see Hyderabad -based Dr Reddy’s share manufacturing expertise and collaborate with Moscow-headquartered R-Pharm on the development of new, as yet unspecified, drug products.
Dr Reddy’s, which has operated in Russia since 1992, said the partnership deepens its engagement in the market and shifts its focus away from the importation of finish products towards local manufacture.
And, while details are yet to be disclosed, the focus on technology-transfer will be welcomed by the Russian Government which made development of the local manufacturing sector a core aim of the Pharma 2020 policy it announced last month.